Suicide Prevention Expert Dr. Holly Robles of Live and Thrive Now to be Featured on CUTV News Radio

BOERNE, TEXAS, UNITED STATES, November 15, 2018 /EINPresswire.com/ — Do you remember how hard it was being a teenager? Ninety percent of adults will go through depression at some point in their lives, but whereas an adult may develop depression over a long period of time, adolescents tend to behave more impulsively. One experience can make them feel as though life is coming to an end and they don't have any options.

People with thoughts of suicide have become so incredibly depressed they can no longer see the goodness within them. They just want the pain to stop. That’s why it's so important for students to reach out to someone who can give them that literal lifeline to hang onto, someone skillful who understands how they feel and knows how to help.

Dr. Holly Robles is a licensed professional counselor and the founder of Live and Thrive Now. Dr. Robles has dedicated her career to making schools safer to prevent teen suicide.

“As teenagers they don’t have cognitive framework to understand that it isn’t the end of the world, which puts them at great risk,” says Dr. Robles. “That’s why we have to reach out to everybody around us. We have to let them know that the resources are there, that there is someone they can go to if they are thinking of suicide or have a friend or a family member that is thinking of suicide, so they know where to take their friend or family member for help.”

This year, Dr. Robles published the Texas Suicide Safer Schools Implementation Guide, focused on suicide prevention. Her research investigations have explored conflict resolution and the effects of cyberbullying on children and adolescents' mental health, as well as understanding secondary general educators' classroom behaviors toward disruptive students.

“I’ve known I wanted to be in this field from the time I was 15 years old,” recalls Dr. Robles. “I struggled with thoughts of suicide myself. felt like nobody in the world could possibly understand what I was going through. Until I saw a counselor. This counselor told me after one visit told me I was going to be somebody amazing, and all it took was one person to believe in me. I walked out of that office and resolved to be that person for someone else and I’ve been doing it ever since.”

While some counselors may tiptoe around these questions and feelings, Dr. Robles listens for their pain and the clues for the truth they’re afraid to tell her: that they want to die.

“When you're depressed, sometimes you think, ‘I can't believe the sun had the nerve to come up today,’” says Dr. Robles. “If we can just find that one thing to keep us going, sometimes that's the thing that's going to get us over the hump until we can get through it. For a lot of kids, it's music. Sometimes it's walking in awe of nature. We have to find whatever it is that helps us to hang on.”

CUTV News Radio will feature Dr. Holly Robles in an interview with Jim Masters on November 19th at 2pm EDT and with Doug Llewelyn on November 26th at 2pm EDT.

Listen to the show on BlogTalkRadio.

If you have a question for our guest, call (347) 996-3389.

For more information on Live and Thrive Now, visit www.liveandthrivenow.com

Lou Ceparano
CUTV News
(631) 850-3314
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

Tissue Diagnostics to help detect cancer in its early stages

tissue diagnostics market

Presence of key market players and advanced healthcare systems profit the tissue diagnostics market of North America

Tissue diagnostics or biopsy is used in oncology and infections to identify the presence of tumor.”

— Lead Analyst @ Market Data Forecast

HYDERABAD, TELANGANA, INDIA, November 15, 2018 /EINPresswire.com/ — A tissue commonly is known, is a group or layer of cells which perform a particular function and comprise vital organic records. Tissue diagnostics involves removal of a small portion of tissue from the patient’s body, which is then processed, analyzed, and tested beneath the magnifier to notice diseases similar to cancer. Advancements within the techniques and instrumentation of medical speciality facilitate for quick and correct determination, and analysis of diseases concerning the tissues. Histopathology is a study of disease in a tissue which can be accomplished by using small biopsies, splendid needle aspiration cytology, and open biopsy or surgical procedure.

The Tissue diagnostics market was valued at USD 3.66 billion in 2018 and is anticipated to be growing at a CAGR of 6.9% to acquire USD 5.11 billion by 2023. Tissue diagnosing technique is claimed to be number one in all the gold standards set in cancer prognosis as the early detection of cancer increases the survival rate of the sufferer. It helps to identify the main reason for the growth of a tumour and also to analyze the future consequences in the patients. The advances in the biotechnology and medical science supported the tissue diagnostics to be more accurate and efficient in the treatment of various cancerous cells.

View Sample Report: https://www.marketdataforecast.com/market-reports/tissue-diagnostics-market-4245/request-sample

Drivers and Restraints:

Tissue diagnostics are executed for screening, analyzing, and monitoring the response of cancer sufferers to therapy. The scope of the tissue diagnostics market consists of major technologies like ISH, IHC, digital pathology and workflow, and unique staining and products like devices and consumables that are used to decide medical facts for the diagnosis of diseases or conditions.

The increasing prevalence of cancer cases around the world is the principal factor driving the growth of the tissue diagnostics market. Furthermore, the increasing awareness of the procedure in the developing economies, rise in the health care expenditure and disposable income of the people, technological innovations in the medical care, changing lifestyles of population, favorable government reimbursements in the developed nations, growing health awareness among different demographics of the people, increase in geriatric population and other factors are also supporting the market for tissue diagnostics.

On the contrary, the lack of awareness among some sections of the population, expenses involved in the procedure, and stringent regulatory frameworks are some of the notable factors that are hindering the growth of the market.

To know more read: https://www.marketdataforecast.com/market-reports/tissue-diagnostics-market-4245/

The full report for the global tissue diagnostics market provides all the information required for the decision making and investing opportunities based on the market size, revenue, history, current trends and future predictions. It also provides the deep sights of the global market based on the product type, application, disease, end-user and regional analysis, along with the competitive landscape.

On the basis of product type, the market is segmented into
• Instruments
• Consumables

On the basis of applications, the market is segmented into
• Hematoxylin and eosin
• Immunohistochemistry
• In Situ Hybridization

On the basis of disease, the market is segmented into
• Lung Cancer
• Pancreatic Cancer
• Breast Cancer
• Lymphoma
• Others

On the basis of end-user, the market is segmented into
• Hospitals
• Diagnostics centers
• Research organizations
• Biotechnology companies
• Contract research organizations

On the basis of region, the market is segmented into
• North America
• Asia Pacific

North America followed by Europe dominates the global tissue diagnostics market, accounting for more than half of the total market share. It is attributed to the presence of key players, sophisticated healthcare facilities, and growing research activities.

Get your customized report: https://www.marketdataforecast.com/market-reports/tissue-diagnostics-market-4245/customize-report

The full report also offers useful insights about leading companies in the global marketplace. Some of the prominent firms dominating the tissue diagnostics market around the world are

• F. Hoffmann-La Roche AG
• Sigma-Aldrich Co. LLC
• Abbott Laboratories
• Agilent Technologies
• BioGenex
• Danaher Corporation

Scope of the report:
• Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
• Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
• A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions

Related reports: Overactive Bladder Treatment Market, Blood Culture Tests Market, Nuclear Medicine Diagnostics Market

About Us:

Market Data Forecast is a firm working in market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for most of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest.

Contact info:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com

MAHANTH
Market Data Forecast
+1 888-702-9626
email us here


Source: EIN Presswire

Varicose veins, commonly found in legs and feet, results in the wrong directional flow of blood.

North America accounts for the lion’s share of the Varicose Vein Treatment market

Around 40% of population in the United States are diagnosed to have the varicose veins condition”

— Lead Analyst @ Market Data Forecast

HYDERABAD, TELANGANA, INDIA, November 15, 2018 /EINPresswire.com/ — The condition of enlarged veins majorly seen in feet and legs is defined as Varicose Vein. It is caused by the physiological condition, secretion changes, genetic disorders and high vital sign. Varicose Vein is generally found in women, obese population and people above the age of 40 years. Hereditary factors and constant position for extended hours also result in this condition. Around 40% of the US population are affected by this disease and more than 30 million people in the country are having venous insufficiency.

The Global Varicose Vein Treatment Market was valued at USD 328.98 million in 2018 and is estimated to reach USD 448.62 million by 2023, growing at a CAGR of 6.4%. Some of the latest advances in varicose vein treatment technology include laser ablation systems, extreme-pulsed-mild therapy, incorporation of closure structures, radiofrequency systems, and ultrasound-guided structures.

View Sample Report: https://www.marketdataforecast.com/market-reports/global-varicose-vein-treatment-market-2617/request-sample

Various advantages like less incisions, quicker recuperation prices, better achievement quotes, much less patient trauma, low adverse aspect consequences, advanced efficacy, and less post-operative headaches provided by the gadgets in the treatment are the principal factors driving the Varicose Veins market. Shift towards less-invasive treatment procedures, accessibility of advanced varicosity treatment devices, the burden of varicosity cases, rising patient compliance & liableness, growing health care expenditure, and rise in ageing population are other factors that are fuelling the Varicose Vein treatment market.

On the flip side, the high prices associate with the treatment, shortage of skilled surgeons, fierce market competition and volatile reimbursement policies are some of the factors hindering the rapid growth of the market.

Read Full Report: https://www.marketdataforecast.com/market-reports/global-varicose-vein-treatment-market-2617/

The full report of global varicose vein treatment market offers complete information about overall market size, share, trends and future developments. It also describes the global market based on the treatment, product, and regional analysis, along with the competitive landscape.

On the basis of mode of treatment, the varicose vein treatment market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation. Endovenous ablation segment accounted for the major share of the market and is likely to continue the same in the forecast period.

Based on the type of products, the global market is segmented into ablation devices, venous closure products, and surgical products. Ablation devices dominated the market in recent years and is anticipated to retain the same in the forecast period.

Based on region, the Global Varicose Vein Treatment Market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is leading the global Varicose Vein Treatment Market. This can be attributed to variety of things such as advancement in technology that leads to advancements in infrastructure, continuous lifestyle changes, increasing awareness towards health and hygiene, increasing government funds, rising prevalence of unhealthy veins, high financial gain, and growing significance of aesthetics. In addition, favourable compensation policies, significantly among the US have significantly boosted the marketplace for in North America.

The Asia Pacific Varicose Vein Treatment Market is anticipated to grow with a double digit CAGR in the forecast period, which can be attributed to a surge in financial gain, improvement in health care infrastructure, and an increase in patient awareness regarding the advantage of seeking early treatment.

Customized Report: https://www.marketdataforecast.com/market-reports/global-varicose-vein-treatment-market-2617/customize-report

The full report also provides data related to leading companies in the world market. Some of the key players in the Varicose Vein Treatment Market include Medtronic plc (Ireland), AngioDynamics, Inc. (U.S.), biolitec AG (Austria), Syneron Medical Ltd. (Israel), Lumenis Ltd. (Israel), Dornier MedTech GmbH (Germany), Energist Group (U.K.), Eufoton s.r.l. (Italy), Vascular Solutions, Inc. (U.S.), Quanta System S.p.A. (Italy), Sciton, Inc. (U.S.), Fotona d.o.o. (Slovenia), BTG plc (U.K.), and Merz Aesthetics (U.S.).

The increasing adoption of technological innovations in the manufacturing, distribution and use of gadgets in the varicose vein treatment offers lucrative growth opportunities for these market giants to capitalize the demand.

The scope of the report:
• Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
• The segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
• A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.

Related reports: Anti-neoplastic Agents Market, Blood Brain Barrier Technologies Market, Breast Imaging Market

About Us:
Market Data Forecast is a firm working in market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for most of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest.

Contact info:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555

MAHANTH
Market Data Forecast
+1 888-702-9626
email us here


Source: EIN Presswire

Medicare on Podcast Brings Clarity to Supplement Plan Options and Medigap

Medicare Supplement Quotes

Go to Youtube and Type in search “best medicare website” and you will see we really are #1 on Youtube.

Complete Medicare Resource Center

Medicare On Video

Armbrecht and his group are committed to helping people get the most current details about Medicare, through whatever channel suits them best.

With so many people searching online for Medicare and its Open Enrollment I knew we had to find a way to reach more people that want the information. Medicare On Podcast was born. Come join us!”

— Keith Armbrecht (Founder Medicare On Podcast)

TREASURE ISLAND, FL, UNITED STATES, November 15, 2018 /EINPresswire.com/ — Treasure Island, FL, USA – Almost 90 percent of adults aged 50 or over are either on Medicare or planning to enroll. The medicare system is incredibly confusing, however, and while Medicare is ubiquitous (according to the Centers for Medicare and Medicaid Services 58.5 million were on Medicare Part A + B as of 2017), over 70 percent of those who are approaching retirement say that they feel they do not have a good enough understanding of how the Medicare program works.

The National Retirement Institute polled more than 1000 adults who were aged over 50 and had a household income of $150,000 or more and found that there was a general feeling of a lack of understanding of how Medicare covers and what Medicare covers.

Health care costs are one of the biggest expenses in retirement, and they are something that people need to take into account when a family is calculating retirement expenses. Keith Armbrecht, the founder of Medicare on Video aims to help with that.

Information at Your Fingertips

The Medicare on Video service has helped more than half a million viewers to understand how the Medicare system works. The goal of the service is to provide people with access to easy to understand information about the different parts of Medicare coverage, which parts are worth your money given your circumstances, and what to do if you have made the wrong choice, or are without coverage.

Armbrecht understands that not everyone uses YouTube or other video websites, and that while thousands of people have subscribed to his channel, to reach as many people as possible it is necessary to use other ways of delivering the information. That's why he has now launched Medicare On Podcast.

The MedicareOnPodcast.com service delivers similar content to help people navigate the confusing system of Medicare, ensuring that they take out the right coverage at the right time.

Are You Fully Covered?

Some believe Medicare Part B is the most important part of the Medicare system, and it covers almost all of the things that the average person would want in a health plan. The other cover options are merely supplemental. There is the option to delay enrollment, and this can sometimes catch people off guard, especially if someone does opt to delay enrollment, and they were not actually eligible to do so, then they could end up being hit with significant penalty charges and having to pay thousands of dollars to backdate their Medicare coverage.

The issue is that someone who misses out on the initial enrollment window for Medicare Part B may have to wait until the next year to enroll. There are special enrollment periods, but not everyone is able to take out the coverage they need in those periods.

To add to the confusion, Medicare Part B carries a fee, while Medicare Part A is free for the majority of people. Retirees are often unwilling to pay for the cover, even though they are going to end up worse off in a lot of ways if they delay their enrollment.

Supporting Informed Choices

The MedicareOn Podcast service offers a series of informative and simple podcasts that help people to understand the service and ensures that people make informed and financially (as well as health-wise) sound decisions. Every month thousands of Americans have to make decisions about their health care, and they are left in a situation where they are going to need to choose a coverage option but they feel like they are simply taking a stab in the dark. More than half of the individuals surveyed in the Harris poll, for example, were unaware that outpatient care is a part of Part B and is not free. Almost one third of the respondents thought that Medicare cost the same amount regardless of a person's circumstances.

Between auto-enrollment, COBRA, and the numerous supplemental coverage plan options, it is very difficult for the average American to know what cover they should be taking out. There are lots of documents and leaflets available through official channels, but the wording on these is sometimes inaccessible, and if you don't know what questions to ask, or which Medicare coverage packages to research it can be doubly confusing.

There are other video services, too. However, since the rules and scope of Medicare can change from time to time, viewers are left wondering if the information on those channels is up to date.

Medicare On Podcast addresses this by ensuring that people know that they are getting the latest information. If a viewer wants the latest information all they need to do is listen to the latest podcast.

Armbrecht and his team are committed to helping people get the latest information about Medicare, through whatever channel suits them best. Some people like reading, some enjoy watching videos, and some prefer to consume podcasts on their way to work. With a selection of different ways to access the same information, it is easier than ever to avoid the pitfalls of deferred enrollment, buying the incorrect Medicare coverage, or over-paying.

Medicare premiums can vary massively, with lower income families paying less than one third the amounts that higher income families may pay. Part D coverage for prescription drugs can be free for some people, but costs money for those earning more than $107,000 per year. Medical coverage is a lifeline for some families, but knowing when to take it out can be tricky. It is useful for helping people to handle deductibles and copays, but it is not always the best option, depending on what other plans the family have taken out.

Medicare on Video and Medicare on Podcast exist to help people understand which options are the most cost effective, and what are the best Medicare coverage for you or your family.

If you would like to know more about Medicare on Podcast, or would like to interview the founder, Keith Armbrecht, simply get in touch using the using the contact form, or the email link.

Keith Armbrecht
Medicare on Video
+1 727-954-5317
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Bacterial Pneumonia Far More Dangerous to the Heart Than Viral Pneumonia, Study Find

Heart complications in patients diagnosed with bacterial pneumonia are more serious than in patients diagnosed with viral pneumonia, according to new research

Heart complications in patients diagnosed with bacterial pneumonia are more serious than in patients diagnosed with viral pneumonia, according to new research.

SALT LAKE CITY, UTAH, USA, November 15, 2018 /EINPresswire.com/ — Heart complications in patients diagnosed with bacterial pneumonia are more serious than in patients diagnosed with viral pneumonia, according to new research from the Intermountain Medical Center Heart Institute in Salt Lake City.

In the study of nearly 5,000 patients, researchers found that patients diagnosed with bacterial pneumonia had a 60 percent greater risk of a heart attack, stroke, or death than patients who had been diagnosed with viral pneumonia.

“We’ve always known pneumonia was a risk factor for a major adverse cardiac event, like a heart attack, within the first 90 days of being diagnosed,” said J. Brent Muhlestein, MD, a cardiovascular researcher with the Intermountain Medical Center Heart Institute. “What we didn’t know was which type of pneumonia was more dangerous. The results of this study provided a clear answer, which will allow physicians to better monitor patients and focus on reducing their risk of a major adverse cardiac event.”

Results of the study were presented at the the American Heart Association Scientific Sessions in Chicago.

The study evaluated 4,792 patients diagnosed with pneumonia who were hospitalized at one of Intermountain Healthcare’s 23 hospitals between January 2007 and May 2014. Each patient was followed for 90 days and tracked for non-fatal heart attacks, stroke, heart failure, or death.

Nearly 80 percent of the patients were diagnosed with bacterial pneumonia, and 34 percent (1,270 patients) of them had a major cardiovascular event within 90 days. At the same time, 21 percent of the patients were diagnosed with viral pneumonia, and 26 percent (258 patients) had a major adverse event within the 90-day window.

“The likely underlying cause is that bacterial pneumonia causes greater inflammation of the arteries compared to viral pneumonia,” said Dr. Muhlestein.

When arteries become inflamed, it destabilizes the layers of plaque that have built up over the years. The unstable plaque can then break loose from the artery wall and cause a blockage, which leads to a heart attack, stroke, or death.

“The practical result of our study is that caregivers should be aware of the greater cardiovascular risks associated with respiratory infections like pneumonia, and especially bacterial pneumonia,” said Dr. Muhlestein. “If a patient has been diagnosed with bacterial pneumonia, treat it aggressively and watch them closely for any signs of a heart attack or stroke. If the patient is taking medications specific to a heart condition, like high blood pressure or cholesterol, they should continue taking those prescribed medications.”

People with known plaque buildup should be especially mindful of things they can do to prevent respiratory infections. Dr. Muhlestein recommends getting a flu shot, a pneumovax, practicing proper hand hygiene year-round (and especially during cold and flu season), and quitting smoking immediately.

The Intermountain Heart Institute at Intermountain Medical Center is part of the Intermountain Healthcare system based in Salt Lake City.

Members of the research team involved in the study include Glendon Scott Steiner; Stacey Knight, PhD; Russell R. Miller III, MD; Tami L. Bair, RN; Benjamin Horne, PhD; Bert Lopansri, MD; Jeffrey L Anderson, MD; John F. Carlquist, PhD; and J. Brent Muhlestein, MD.

Jess Gomez
Intermountain Medical Center
801-507-7455
email us here


Source: EIN Presswire

Wyoming Mesothelioma Victims Center Now Urges a Navy Veteran with Mesothelioma in Wyoming to Call Them for Direct Access to The Nation's Most Capable Lawyers for The Best Possible Compensation Results

Our bottom line is we want a US Navy Veteran with mesothelioma in Wyoming to receive the very best possible financial compensation-and can help you with lawyers who will get you the best results.”

— Wyoming Mesothelioma Victims Center

NEW YORK, NEW YORK, USA, November 15, 2018 /EINPresswire.com/ — The Wyoming Mesothelioma Victims Center is now urging a US Navy Veteran who has recently been diagnosed with mesothelioma in Wyoming or their family to call them anytime at 800-714-0303 for some extremely honest advice about how not to lose out on their compensation. The group says, "Our bottom line is we want a US Navy Veteran with mesothelioma in Wyoming to receive the very best possible financial compensation and we offer people like this on the spot access to the nation's most capable lawyers to get the job done." http://Wyoming.MesotheliomaVictimsCenter.Com

The Wyoming Mesothelioma Victims Center is appealing to a Navy Veteran with mesothelioma who was exposed to asbestos on a US Navy ship, a submarine or shipyard to call them anytime at 800-714-0303 especially if their exposure to asbestos included a shipyard in Norfolk, Virginia; Bremerton, Washington; Groton, Connecticut; Bangor, Maine; Long Beach, California; Hunters Point, California; or in Philadelphia, Pennsylvania. Asbestos exposure at a shipyard can dramatically increase the potential financial compensation potential for a Navy Veteran with mesothelioma.http://Wyoming.MesotheliomaVictimsCenter.Com

The Delaware Mesothelioma Victims Center is urging a diagnosed US Navy Veteran with mesothelioma in Wyoming to steer clear of Internet or cable TV advertisements that suggest the following:

* "No lawsuits needed" ("To get properly compensated for mesothelioma a US Navy Veteran with this rare cancer will need extremely skilled lawyers and a lawsuit probably will be involved")

* "A book about mesothelioma" ("The book about mesothelioma is a simple way for a law firm you do not know to get your contact information. Why settle for a generic book about mesothelioma when you can be talking directly to some of the nation's most experienced mesothelioma attorneys within minutes if you call us?")

* "99% success rate" (success rate means nothing if the law firm can't back it up with settlement results-that they created)

* "A Federal Mesothelioma Compensation Claim Center" ("They do not exist")

The Wyoming Mesothelioma Victims Center wants to emphasize their free services are available to people anywhere in Wyoming in communities such as Cheyenne, Casper, Laramie, Jackson hole, Gillette, or Rock Springs. http://Wyoming.MesotheliomaVictimsCenter.Com

For the best possible mesothelioma treatment options near Wyoming the Wyoming Mesothelioma Victims Center strongly recommends the following heath care facility with the offer to help a diagnosed victim, or their family get to the right physicians at this very prestigious hospital.

* The Mayo Clinic Rochester, Minnesota:https://www.mayoclinic.org/departments-centers/mayo-clinic-cancer-center.

Individuals in the state of Wyoming could have been exposed to asbestos while serving in the US Navy, or while working at a power plant, oil refinery, in the oil, gas or coal production business, as a plumber, a boiler technician, as an auto repairman, as an electrician, or in the construction industry. In most cases, the exposure to asbestos caused mesothelioma at one of these types of workplaces and the exposure took place in the 1950′s, 1960′s, 1970′s, or 1980′s. Mesothelioma typically takes three to five decades to appear.

For more information about mesothelioma please refer to the National Institutes of Health’s web site related to this rare form of cancer: https://www.cancer.gov/types/mesothelioma

Michael Thomas
Wyoming Mesothelioma Victims Center
+1 800-714-0303
email us here


Source: EIN Presswire

myStrength’s Evidence-Based, Non-Opioid Approach to Chronic Pain Helps Stem Opioid Use by Nearly 50%

The Opioid Crisis: myStrength Offers Hope and Help for Recovery

RCT Preliminary Findings Show Digital Behavioral Healthcare Tools Significantly Reduce Opioid Use

This work is so encouraging. This provides evidence-based support for adding myStrength’s digital behavioral self-care to chronic pain management protocols.”

— Dr. Abigail Hirsch, myStrength’s Chief Clinical Officer

DENVER, CO, UNITED STATES, November 15, 2018 /EINPresswire.com/ — Chronic pain and subsequent opioid addiction in America remain at epidemic levels. Studies show only about one in five people in need of substance use treatment receive care.1

While much focus is being applied to stemming the flow of opioid-based medications into our healthcare system, few scalable resources are currently available to help the American healthcare consumer understand the appropriate role for such medications – and the breadth of alternative approaches for pain management.

myStrength is proud to introduce expansive new resources to support prevention, treatment and recovery from opioid use disorders (OUDs). This expansion is made in conjunction with groundbreaking preliminary results from a recent Pain Management Randomized Controlled Trial (RCT).

OPIOID USE DISORDER RESOURCES
myStrength’s evidence-based, self-care tools inform individuals about opioid use disorders and the recovery process, and offer robust, alternative strategies to opioids and other substances, including the risks of continued use. The comprehensive Opioid Recovery Program emphasizes science-based, proven treatment options – particularly, medication-assisted treatment (MAT

The 36 diverse new Opioid Recovery activities feature interactive, multi-media, personalized activities that educate individuals about treatment options that promote successful recovery. As part of the expansion, myStrength developed interactive resources featuring peers in recovery, as well as addiction specialists. Relatable, evidence-based content and self-care tools help individuals manage their decisions and understand they are not alone in their journey. Topics include treatment options, why treatment works, what is involved and what to expect, inspiration from others who have succeeded in their recovery, and new recovery skills. The content is applicable to a broad audience, including those who are questioning their opioid use, worried about a loved one or already engaged in treatment.

These new OUD resources are a significant addition to myStrength’s whole-person support, which includes management of existing substance use disorders (SUDs), and comorbid conditions like depression, anxiety, stress, and sleep issues – all of which can amplify substance use challenges and addictive behaviors. Adding myStrength into recovery care models elevates individuals as active partners to their care team in these complicated and highly-personal decisions. myStrength is available 24/7 through payers and providers and can be accessed from any mobile device or computer, even at a public library.

RANDOMIZED CONTROLLED TRIAL (RCT)
The RCT looked at the impact of myStrength, a digital behavioral health platform for chronic pain management, as well as depression, anxiety, insomnia, stress and substance use disorders (among other conditions), compared to treatment as usual. Trial participants with chronic pain were assessed at baseline, 14 days, four weeks, and eight weeks. Intervention condition participants were re-assessed at six months. Control participants were offered the program at eight weeks and re-assessed one month later.

Pain functioning was assessed with the Global Pain Scale (GPS). Need for medication was assessed with an average of a need for medication question on the GPS and the Opioid Misuse Scale.

The RCT results were accepted for presentation at ISPOR Europe 2018 in Barcelona, Spain, November 10-14.

PRELIMINARY RCT RESULTS
Short-term results from the Active Participant Group had significantly lower GPS (better functioning) than other groups at 14 days and four weeks. Active participants also indicated less need for medication at 14 days and four weeks. Statistical modeling indicates that active participants reduced their self-reported need for medication and problematic opioid use by nearly 50% as compared to controls.

“The myStrength platform helps people learn tools to improve their pain functioning, and also results in less reported medication usage and dependence,” said Dr. Abigail Hirsch, myStrength’s Chief Clinical Officer. “This work is so encouraging. We desperately need highly scalable options to bring quality behavioral health resources to primary care, emergency departments and other settings on the front lines of treating chronic pain and managing downstream impacts of opioids and other substances. This provides evidence-based support for adding myStrength’s digital behavioral self-care to chronic pain management protocols.”

About myStrength
myStrength, Inc. is a recognized leader in digital behavioral health. myStrength greatly enhances traditional care models, while addressing issues of cost, lack of access, and stigma, to deliver mental health and well-being resources at scale. Grounded in evidence-based approaches, our platform targets the most prevalent and costly behavioral health conditions ─ empowering consumers with innovative self-care resources to manage and overcome challenges with depression, anxiety, stress, substance use disorders, chronic pain and sleep. myStrength collaborates with more than 100 health plans, integrated health systems, EAPs, disease management providers, managed and community behavioral health providers, strategic alliances, ACOs and FQHCs. For more information, visit www.myStrength.com. To schedule a demo, please contact www.mystrength.com/contact

1 https://healthcare.mckinsey.com/why-we-need-bolder-action-combat-opioid-epidemic

Rebecca McIlwaine
myStrength
+1 303-517-2601
email us here
Visit us on social media:
LinkedIn


Source: EIN Presswire

New finding adds proof microbes are at Alzheimer’s “crime scene”, says Dr. Leslie Norins, CEO of Alzheimer’s Germ Quest

Bacteria found in brains further proof that a microbe may trigger the disease

Bacteria in brain samples of people with Alzheimer's was found by a U.S. scientist is further proof that a microbe may trigger the disease.

These unexpected brain bacteria add urgency to Alzheimer's infection research.”

— Dr. Leslie Norins

NAPLES, FL, UNITED STATES, November 14, 2018 /EINPresswire.com/ — “The suspects have been reliably placed at the crime scene,” says Leslie Norins, MD, PhD, analyzing the accumulated evidence that microbes inhabit or visit the brain and likely trigger Alzheimer’s disease. Dr. Norins is CEO of Alzheimer’s Germ Quest, Inc., an independent advocacy group for Alzheimer’s research.

“The clincher,” he says, is the research presented by Rosalinda Roberts at the recent Society for Neuroscience meeting, and as featured in Science. She and colleagues at the University of Alabama, using electron microscopy, unexpectedly found bacterial forms penetrating and inhabiting brain tissue samples from healthy human brains. Similar evidence was found in samples from patients with schizophrenia, which was the disease they were studying.

The research found the “surprise” bacteria were “abundant” in the hippocampus, and substantia nigra, two brain areas also critical to both Alzheimer’s and Parkinson’s diseases.

Dr. Norins says Roberts’ findings of bacteria where they were unexpected immediately brought to his mind the discovery by Marshall and Warren of previously overlooked H. pylori bacteria inhabiting the stomach lining—from where they could cause gastric ulcers in some people.

Dr. Norins says this adds to the convincing evidence he heard at a recent Swiss conference, where leading researchers added to accumulating information indicating that one or more infectious agents could trigger Alzheimer’s.

“This pretty much wraps it up,” he says. “Microorganisms of all sorts live in or visit the brain. Now the major mystery is what makes the killer ones actually pull the trigger.”

Dr. Norins says this will require the National Institutes of Health and Alzheimer’s advocacy organizations to prioritize funding of the necessary research on Alzheimer’s infectious agents, instead of allocating most of their funds to traditional studies of brain proteins amyloid and tau.

He says, “If these infection leads prove fruitful, we could get a simple blood test for Alzheimer’s, an antibiotic to treat it, and even a preventive vaccine. There’s no downside, as whatever is found will be important new knowledge about the brain and its microbiome.”

Alzheimer’s Germ Quest, Inc. is a public benefit corporation headquartered in Naples, Florida. It sponsors a $1 million challenge award for the researcher who proves an infectious agent is the root cause of Alzheimer’s disease.

Mollie Page
Alzheimer's Germ Quest
+1 2397777243
email us here


Source: EIN Presswire

Launch of CHUM school of artificial intelligence applied to the health sector

Today, CHUM and Universite de Montreal announce the creation of the Ecole de l'intelligence artificielle en sante du CHUM (EIAS).

MONTREAL, QUEBEC, CANADA, November 14, 2018 /EINPresswire.com/ — Today, CHUM and Universite de Montreal announce the creation of the first school of artificial intelligence applied to the health sector from a Francophone environment, the Ecole de l'intelligence artificielle en sante du CHUM (EIAS). Established by CHUM, through its Academy, in conjunction with the Universite de Montreal, its faculties and schools, the objective of the EIAS is to support and assist health system stakeholders in the adoption, implementation and promotion of AI, for the benefit of its teams, patients and the general public. The EIAS will address topics such as social, legal and ethical acceptability, and the transformation of trades, professions, practices, teams, the organization and the health system.

AI Serving Health

AI offers unprecedented possibilities in the health sector, through its capacity to analyze massive amounts of data to better understand, detect and treat disease, and through robotization. As a disruptive innovation, AI will rapidly and profoundly transform care, teaching, research and health systems management. However, the stakes involved in implementing AI in this field are considerable and require a structured approach if the implementation is to be a success and bring real value to healthcare teams and the public. “The school we are opening today with our partners aims to support health system stakeholders in this transformation by providing them with what they need to change the culture, organizational structure and management, as well as by offering support to those involved and by measuring impacts throughout the transformation process,” states Dr. Fabrice Brunet, president and CEO of CHUM. “It is the first artificial intelligence school in the world from a Francophone environment to focus on the development of human capacities and the implementation of AI in a real environment, and will raise CHUM and the Universite de Montreal profiles internationally through partnerships with more than 100 university hospitals.”

A School for All Levels of Proficiency

The EIAS is geared towards all health professionals working in health systems and in companies directly or indirectly involved with health, including all its determinants (environment, nutrition, urbanization, economy, etc.). As of January 2019, it will progressively deliver programs adapted to a varied clientele and to their level of AI proficiency. “By raising awareness through "lunch and learns" or short videos, skills development through diploma programs, familiarization through practical workshops and simulation, and field experimentation, the EIAS will be able to meet the needs of diverse health stakeholders, and will do so in several languages,” notes Nathalie Beaulieu, Chief Learning Officer of CHUM. “Nimble and proactive, the school is distinguished by its flexible and contextualized nature. It places the human being at the centre of the transformation to increase its capacity to heal.”

The EIAS is built on five pillars: the training curriculum, the faculty, internship sites, career development and value creation. The departments and services of CHUM are an integral part of it, not only as an internship center, but also as a place of implantation and experimentation of the AI. As pointed out by Dr. Vincent Oliva, Head of the Department of Radiology and Nuclear Medicine at CHUM: “AI has already begun to revolutionize medicine. It is now used not only to assess brain volume for the detection of Alzheimer's disease, but also to evaluate cardiac function, detect lung nodules and predict cancers. It will redefine and enhance the role of medical imaging.”

EIAS: A Joint Partnership

The creation of the EIAS would not have been possible without the commitment of the Universite de Montreal, its faculties and its schools. "In addition to contributing to advances in artificial intelligence, the Universite de Montreal supports its deployment within society, by training workers in its use and by working to ensure that its development is ethical and responsible. Becoming partners with this new school at CHUM enables us to make a positive contribution to the transformation of the healthcare environment, where artificial intelligence has the potential to significantly improve our quality of life," declares the vice-rector of student and academic affairs, Louise Beliveau.

CHUM will begin by working closely with the Universite de Montreal's faculty of arts and science and Mosaic HEC, HEC Montreal's multidisciplinary training and research centre specializing in innovation and creativity management. Full professors and students from Mosaic HEC Montreal will contribute to developing the content of the school's activities. The EIAS can also count on support from several other institutional and private partners.

Innove-Action: Three Days to Reinvent Health

The announcement of the creation of the Ecole de l'intelligence artificielle en sante du CHUM is included in the program of the Innove-Action event, which takes place from November 13 to 15 at the Centre de recherche du CHUM (CRCHUM). Over the course of these three days, more than 1200 professionals, researchers, students, managers, decision-makers, patients and industrial partners will participate in some forty interactive activities under the theme of reinventing health: augmented intelligence and innovation ("Reinventer la sante : intelligence augmentee et innovations"). For more information and to consult the program: innoveactionchum.ca. To follow the event on a mobile device, download the application for IOS and Android EventMobi (code: Innoveaction2018).

– 30 –

About Centre hospitalier de l'Universite de Montreal (CHUM)
The Centre hospitalier de l’Universite de Montreal is an innovative hospital devoted to serving patients. It provides the highest quality specialized and ultraspecialized care to patients and the general public all over Quebec. Through its unique expertise and innovations, its aim is to improve the health of the adult and aging population. As the Universite de Montreal hospital, CHUM is dedicated to care, research, teaching, health promotion, and the assessment of technology and health intervention methods in order to continually improve the quality of care and the health of the population. Since the fall of 2017, patients and their families have been able to enjoy a renewed hospital experience at CHUM's new facilities. chumontreal.qc.ca

Lucie Dufresne
Centre hospitalier de l'Université de Montréal
+1 514-890-8000
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

HIPAA Complaints Leading to Fewer Formal Changes in Healthcare Privacy & Security Programs, Melamedia Analysis Finds

Latest analysis to take a fuller look at privacy and data security actions in the first 15 years of HIPAA enforcement

Patient complaints continue to be an effective way to get healthcare organizations to make changes to their privacy and security programs.”

— Dennis Melamed, Editor, Health Information Privacy/Security Alert

ALEXANDRIA, VA, US, November 14, 2018 /EINPresswire.com/ — Fewer healthcare organizations are being required to make changes to their privacy and security programs due to patient complaints, according to an analysis of HHS data from 2008 through July 2018 by the independent newsletter, Health Information Privacy/Security Alert.

However, patient involvement is still playing a significant role in forcing healthcare organizations to make changes to their HIPAA programs as OCR responds to those complaints.

Actionable complaints invoking HIPAA, which were filed with the HHS Office for Civil Rights, fell steeply after 2014, according to the analysis. In 2015, 733 patient complaints prompted healthcare entities to make changes in health data privacy and security policies after OCR investigated compared to 1,288 in 2014.

That number fell again to 727 complaints in 2016, but started to rise again in 2017 when 863 patient complaints resulted in changes to healthcare policies and procedures. The overall level appears to be the on the same pace for 2018 with 515 patient complaints forcing changes through July 31.

“Patient complaints still continue to be an effective way to get healthcare organizations to make changes to their privacy and security programs,” observed Dennis Melamed, editor and publisher of Health Information Privacy/Security Alert. “OCR’s program to provide technical assistance is also partly based on patient complaints, and there have been thousands of instances in recent years in which healthcare entities have made changes In fact, OCR reported 3,000 instances in which it has provided such assistance through the first six months of 2018.”

A fuller exploration of health data privacy and security enforcement will be conducted in Melamedia’s 15th Annual Year-End Review of Medical Privacy and Data Security Enforcement. The webinar features Iliana Peters, former OCR Acting Deputy Director for Health Information Privacy.

Melamedia, LLC is regulatory affairs research and education company and has published Health Information Privacy/Security Alert – the first independent newsletter tracking health data confidentiality and security issues – since 1997.

Katalin Sugar
Melamedia
email us here
+1 703-704-5665


Source: EIN Presswire